Save time and get answers to complex questions with AI chat
Does lipitor's effectiveness decrease with high fat meals?Drugpatentwatch skyrizi biologic patent analysis?When will latisse patent expire?Prolia and osteonecrosis?Zemdri nce gain exclusivity 2028 patent 2031?
See the DrugPatentWatch profile for Emgality
Emgality® (galcanezumab‑mimm) – 120 mg / mL pre‑filled pen
Emgality is a monoclonal antibody that blocks the calcitonin gene‑related peptide (CGRP) pathway, which is involved in migraine pathophysiology. The 120 mg / mL pre‑filled pen delivers a single 120 mg dose (1 mL) in one injection. It is usually prescribed for the prevention of episodic or chronic migraine in adults.
The 120 mg / mL Emgality pen is a convenient, once‑monthly preventive therapy for migraine. It is ready‑to‑use, so the only real steps are to store it properly, inject it correctly, and keep track of your monthly schedule. As always, use it exactly as prescribed by your healthcare professional, and reach out if you have any concerns—whether about side effects, efficacy, or anything else.
Other Questions About Emgality :